Back
Day Range
$9.46
$10.77
52-Week Range
$9.46
$23.85
Volume
400
50D / 200D Avg
$15.11
/
$17.62
Prev Close
$9.46
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 22.8 | 0.4 |
| P/B | 2.1 | 2.9 |
| ROE % | 8.5 | 3.7 |
| Net Margin % | 3.8 | 3.8 |
| Rev Growth 5Y % | 5.3 | 10.0 |
| D/E | 1.5 | 0.2 |
Key Takeaways
Revenue grew 5.30% annually over 5 years — modest growth
Earnings declined -37.20% over the past year
Negative free cash flow of 0.0
Revenue growth is decelerating — 1Y growth trails 5Y average by 5.90%
Growth
Revenue Growth (5Y)
5.30%
Revenue (1Y)-0.60%
Earnings (1Y)-37.20%
FCF Growth (3Y)N/A
Quality
Return on Equity
8.50%
ROIC5.90%
Net Margin3.81%
Op. Margin8.31%
Safety
Debt / Equity
1.53
Current Ratio0.52
Interest Coverage3.23
Valuation
P/E Ratio
22.79
P/B Ratio2.09
EV/EBITDA18.16
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0.60% | Revenue Growth (3Y) | 2.94% |
| Earnings Growth (1Y) | -37.20% | Earnings Growth (3Y) | -23.29% |
| Revenue Growth (5Y) | 5.30% | Earnings Growth (5Y) | -12.78% |
| Profitability | |||
| Revenue (TTM) | 2.39B | Net Income (TTM) | 91.30M |
| ROE | 8.50% | ROA | 2.56% |
| Gross Margin | 8.31% | Operating Margin | 8.31% |
| Net Margin | 3.81% | Free Cash Flow (TTM) | 0.0 |
| ROIC | 5.90% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.53 | Current Ratio | 0.52 |
| Interest Coverage | 3.23 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 22.79 | P/B Ratio | 2.09 |
| P/S Ratio | 0.87 | PEG Ratio | -0.88 |
| EV/EBITDA | 18.16 | Dividend Yield | 0.02% |
| Market Cap | 2.08B | Enterprise Value | 3.61B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.39B | 2.41B | 2.26B | 2.12B | 1.95B |
| Net Income | 91.30M | 145.37M | 155.14M | 178.53M | 157.79M |
| EPS (Diluted) | 0.40 | 0.64 | 0.69 | 0.79 | 0.69 |
| Gross Profit | 198.94M | 1.36B | 548.45M | 275.71M | 259.56M |
| Operating Income | 198.94M | 256.81M | 259.21M | 275.71M | 259.56M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.56B | 3.99B | 3.69B | 3.58B | 3.52B |
| Total Liabilities | 2.57B | 2.84B | 2.59B | 2.54B | 2.59B |
| Shareholders' Equity | 997.84M | 1.15B | 1.10B | 1.04B | 925.18M |
| Total Debt | 1.53B | 1.72B | 1.52B | 1.51B | 1.61B |
| Cash & Equivalents | 0.0 | 288.83M | 193.15M | 179.65M | 268.55M |
| Current Assets | 417.34M | 725.23M | 621.20M | 581.00M | 635.40M |
| Current Liabilities | 805.48M | 1.17B | 1.18B | 1.06B | 886.29M |